Establishment and validation of a prognostic nomogram for severe fever with thrombocytopenia syndrome: A retrospective observational study

PLoS One. 2024 Oct 24;19(10):e0311924. doi: 10.1371/journal.pone.0311924. eCollection 2024.

Abstract

Background: Several scoring systems have been proposed to predict the risk of death due to severe fever with thrombocytopenia syndrome (STFS), but they have limitations. We developed a new prognostic nomogram for STFS-related death and compared its performance with previous scoring systems and the Acute Physiology and Chronic Health Evaluation score (APACHE II Score).

Methods: A total of 292 STFS patients were retrospectively enrolled between January 2016 and March 2023. Boruta's algorithm and backward stepwise regression were used to select variables for constructing the nomogram. Time-dependent receiver operating characteristic (ROC) curves and clinical decision curves were generated to compare the strengths of the nomogram with others.

Results: Age, Sequential Organ Failure Assessment Score (SOFA score), state of consciousness, continuous renal replacement therapy (CRRT), and D-dimer were significantly correlated with mortality in both univariate and multivariate analyses (P<0.05). We developed a nomogram using these variables to predict mortality risk, which outperformed the SFTS and APACHE II scores (Training ROC: 0.929 vs. 0.848 vs. 0.792; Validation ROC: 0.938 vs. 0.839 vs. 0.851; P<0.001). In the validation set, the SFTS model achieved an accuracy of 76.14%, a sensitivity of 95.31%, a specificity of 25.00%, a precision of 77.22%, and an F1 score of 85.32%. The nomogram showed a superior performance with an accuracy of 86.36%, a precision of 88.24%, a recall of 93.75%, and an F1 score of 90.91%.

Conclusion: Age, consciousness, SOFA Score, CRRT, and D-Dimer are independent risk factors for STFS-related death. The nomogram based on these factors has an excellent performance in predicting STFS-related death and is recommended for clinical practice.

Publication types

  • Observational Study
  • Validation Study

MeSH terms

  • APACHE
  • Adult
  • Aged
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Humans
  • Male
  • Middle Aged
  • Nomograms*
  • Organ Dysfunction Scores
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Severe Fever with Thrombocytopenia Syndrome* / diagnosis
  • Severe Fever with Thrombocytopenia Syndrome* / mortality

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D

Grants and funding

This work is funded by Nanjing Second Hospital Reserve Talent Program (0316301), Jiangsu Provincial Health and Health Commission 2021 Medical Research Projects (Jiangsu Health Science and Education (2021) No. 149), 2021 Nanjing Health Science and Technology Development Special Funds Project (YKK21121), Postgraduate Research & Practice Innovation Program of Jiangsu Province (SJCX23_0856) and Nanjing Infectious Disease Clinical Medical Center; Innovation center for infectious disease of Jiangsu Province(NO.CXZX202232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.